Research Journal of Pharmacy and Technology

SCOPUS
  • Year: 2019
  • Volume: 12
  • Issue: 7

Molecular Docking Studies of potential anticancer agents from Ocimum basilicum L. against human colorectal cancer regulating genes: An insilico approach

  • Author:
  • Balakrishnan Purushothaman1,2, Nagarasan Suganthi2, Arunachalam Jothi3, Kumaran Shanmugam1
  • Total Page Count: 5
  • Page Number: 3423 to 3427

1Department of Biotechnology, Periyar Maniammai Institute of Science and Technology, Thanjavur – 613403, Tamilnadu, India

2Tan Bio R and D Solution, Periyar Technology Business Incubator, Vallam, Thanjavur – 613403, Tamilnadu, India

3Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA University, Thanjavur – 613 401, Tamilnadu, India

Online published on 24 December, 2019.

Abstract

Colorectal cancer (CRC) ranks third in cancer deaths all over the world. Mortality and incidence rates of CRC in India is constantly increasing due to change in food habits, life style etc., Ocimum basilicum has been reported for constituents like eugenol, germacrene, gurjunene, menthol and β-elemene with anticancer properties. As an initiative, these chemical constituents were studied against human colorectal biomarkers such as KRAS, NRAS, BRAF (Oncogenes); PIK3CA, P53, DCC (Tumor suppressor genes) through molecular docking. Autodock 4.2 software was used to understand the drug-biomolecular interactions; binding mechanism of drug (ligand) and receptor (target); binding energy and bond length. The mutant type proteins of these markers were analyzed with specific to their expression codons against these O. basilicum constituents. Our results revealed that constituents of O. basilicum have excellent binding energies against colorectal cancer genes.

Keywords

Colorectal cancer, Regulating, Oncogene, Tumor suppressor gene, Biomarkers, Molecular docking